• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对稳定心力衰竭人群中 B 型利钠肽的分析:对治疗有重要的辅助作用。

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

机构信息

Department of Cardiology, Heart Failure Unit, St. Vincent's University Hospital and University College Dublin, Elm Park, Dublin 4, Ireland.

出版信息

Ir J Med Sci. 2011 Jun;180(2):355-62. doi: 10.1007/s11845-011-0689-1. Epub 2011 Mar 3.

DOI:10.1007/s11845-011-0689-1
PMID:21369749
Abstract

AIM

To examine the prognostic importance of absolute values and change in values of BNP in patients with stable heart failure (HF).

METHODS

Five-hundred and fifty-nine patients attending a disease management programme were categorized into tertiles of BNP (group 1; ≤ 95 pg/ml, group 2; 96-249 pg/ml and group 3; ≥ 250 pg/ml). A change in BNP between two stable visits was recorded. Patients were followed up for 1 year for death and a composite morbidity measure of HF hospitalization, all-cause hospitalization, unscheduled visits for clinical deterioration(UC) of HF using survival analysis.

RESULTS

The risk of the combined morbidity outcome increased with increasing tertiles of BNP (Log rank = 17.8 (2), p < 0.001). Furthermore, a 50 and 25% increase in BNP predicted morbidity in stable HF patients with an initial BNP > 200 pg/ml (p = 0.02) and > 450 pg/ml (p = 0.03), respectively.

CONCLUSION

In a stable community HF population, an elevated BNP or an increase in BNP predicts an adverse prognosis thereby potentially identifying a population in need of closer clinical follow-up.

摘要

目的

探讨稳定心力衰竭(HF)患者 BNP 绝对值和变化值的预后意义。

方法

将 559 例参加疾病管理计划的患者按 BNP 三分位数分为三组(第 1 组:≤95pg/ml;第 2 组:96-249pg/ml;第 3 组:≥250pg/ml)。记录两次稳定就诊之间 BNP 的变化。使用生存分析对患者进行为期 1 年的随访,以死亡和 HF 住院、全因住院、因 HF 临床恶化(UC)而计划外就诊的复合发病率为终点。

结果

随着 BNP 三分位数的增加,复合发病率的风险增加(对数秩检验=17.8(2),p<0.001)。此外,在初始 BNP>200pg/ml(p=0.02)和>450pg/ml(p=0.03)的稳定 HF 患者中,BNP 增加 50%和 25%分别预测发病率。

结论

在稳定的社区 HF 人群中,BNP 升高或 BNP 增加预示着不良预后,从而可能确定需要更密切临床随访的人群。

相似文献

1
Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.对稳定心力衰竭人群中 B 型利钠肽的分析:对治疗有重要的辅助作用。
Ir J Med Sci. 2011 Jun;180(2):355-62. doi: 10.1007/s11845-011-0689-1. Epub 2011 Mar 3.
2
B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.B型利钠肽可能预测非因心力衰竭入院的老年人的预后。
Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):636-642. doi: 10.1016/j.numecd.2018.02.017. Epub 2018 Mar 2.
3
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
4
Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.短期随访脑钠肽对心力衰竭住院患者的预后价值
BMC Cardiovasc Disord. 2017 Aug 3;17(1):215. doi: 10.1186/s12872-017-0632-0.
5
Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.经治疗病情稳定的慢性收缩性心力衰竭患者中N末端B型利钠肽原及多普勒左心室舒张变量的预后价值
Am J Cardiol. 2008 Aug 15;102(4):463-8. doi: 10.1016/j.amjcard.2008.03.083. Epub 2008 May 24.
6
B-type natriuretic peptide levels in obese patients with advanced heart failure.晚期心力衰竭肥胖患者的B型利钠肽水平
J Am Coll Cardiol. 2006 Jan 3;47(1):85-90. doi: 10.1016/j.jacc.2005.08.050. Epub 2005 Dec 15.
7
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.心血管危险因素稳定门诊患者中N末端B型利钠肽原/ B型利钠肽的摩尔比与心力衰竭相关事件的关系
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
8
Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.B型利钠肽评估对失代偿性心力衰竭后稳定的低风险非缺血性心肌病门诊患者的预后价值
J Am Coll Cardiol. 2008 Jun 17;51(24):2329-35. doi: 10.1016/j.jacc.2007.11.085.
9
Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.心力衰竭史对 BNP 诊断和预后价值的影响:来自 B 型利钠肽用于急性呼吸困难评估(BASEL)研究的结果。
Int J Cardiol. 2010 Jul 23;142(3):265-72. doi: 10.1016/j.ijcard.2008.12.214. Epub 2009 Jan 29.
10
[Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].[脑钠肽及心肺运动试验对接受β受体阻滞剂治疗的收缩性心力衰竭患者的预后价值]
Rev Esp Cardiol. 2008 Mar;61(3):260-8.

引用本文的文献

1
The use of biomarkers in the patient with heart failure.心力衰竭患者中生物标志物的应用。
Curr Cardiol Rep. 2013 Jun;15(6):372. doi: 10.1007/s11886-013-0372-4.

本文引用的文献

1
B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.B型利钠肽可预测慢性心力衰竭患者从居家护士护理中获益的情况。
J Card Fail. 2009 Apr;15(3):233-40. doi: 10.1016/j.cardfail.2008.11.002. Epub 2008 Dec 18.
2
B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events.在常规超声心动图检查时,B 型利钠肽和阻抗心动描记术可预测随后的心力衰竭事件。
J Card Fail. 2009 Feb;15(1):41-7. doi: 10.1016/j.cardfail.2008.09.003. Epub 2008 Dec 2.
3
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
脑钠肽指导与症状指导的心力衰竭治疗:老年充血性心力衰竭患者强化治疗与标准药物治疗试验(TIME-CHF)随机试验
JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2.
4
Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure.慢性心力衰竭患者 B 型利钠肽短期变异的相关性。
Wien Klin Wochenschr. 2008;120(21-22):672-8. doi: 10.1007/s00508-008-1099-x.
5
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).缬沙坦心力衰竭试验(Val-HeFT)中N末端脑钠肽前体变化的预后价值
J Am Coll Cardiol. 2008 Sep 16;52(12):997-1003. doi: 10.1016/j.jacc.2008.04.069.
6
Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.门诊静脉利尿剂治疗;显著降低急性失代偿性心力衰竭住院率的潜力。
Eur J Heart Fail. 2008 Mar;10(3):267-72. doi: 10.1016/j.ejheart.2008.01.003. Epub 2008 Mar 4.
7
Natriuretic peptides.利钠肽
J Am Coll Cardiol. 2007 Dec 18;50(25):2357-68. doi: 10.1016/j.jacc.2007.09.021.
8
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.慢性心力衰竭门诊患者的系列生物标志物测量:随时间变化的重要性。
Circulation. 2007 Jul 17;116(3):249-57. doi: 10.1161/CIRCULATIONAHA.107.694562. Epub 2007 Jun 25.
9
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.急性失代偿性心力衰竭患者入院时B型利钠肽水平与院内死亡率
J Am Coll Cardiol. 2007 May 15;49(19):1943-50. doi: 10.1016/j.jacc.2007.02.037. Epub 2007 Apr 30.
10
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.血浆脑钠肽指导治疗改善心力衰竭预后:STARS-BNP多中心研究
J Am Coll Cardiol. 2007 Apr 24;49(16):1733-9. doi: 10.1016/j.jacc.2006.10.081. Epub 2007 Apr 2.